Showing results (81-90 of 280) with videos related to

Sort By:
Pageof 28
Gastroenterology|January 7, 2014
Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitisChristophe Corpechot, Farid Gaouar, Ahmed El Naggar, et al.
Vaccine|August 19, 2003
Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccinationThomas Hanslik, Pierre-Yves Boëlle, Michael Schwarzinger, et al.
AIDS (London, England)|February 14, 2006
Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factorsFirouzé Bani-Sadr, Fabrice Carrat, Pierre Bedossa, et al.
Journal of Medical Virology|April 14, 2012
Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray systemAntoine Huguenin, Lauryane Moutte, Fanny Renois, et al.
The New England Journal of Medicine|December 2, 2011
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitisDavid Saadoun, Michelle Rosenzwajg, Florence Joly, et al.
The Journal of Infection|April 8, 2014
Influenza C virus high seroprevalence rates observed in 3 different population groupsNicolas Salez, Julien Mélade, Hervé Pascalis, et al.
BMC Public Health|September 4, 2024
Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020-2022Simon Galmiche, Tiffany Charmet, Arthur Rakover, et al.
Virology Journal|January 29, 2014
Determinants of individuals' risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents--a CoPanFlu cross-sectional studyFred Andayi, Pascal Crepey, Alexia Kieffer, et al.
Scientific Reports|April 25, 2024
Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture modelBenjamin Glemain, Xavier de Lamballerie, Marie Zins, et al.
Gut|March 17, 2007
Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patientsChristopher Payan, Adeline Pivert, Patrice Morand, et al.
Pageof 28